Your browser doesn't support javascript.
loading
Factors Predictive of Remission of Chronic Anterior Uveitis.
Sobrin, Lucia; Pistilli, Maxwell; Dreger, Kurt; Kothari, Srishti; Khachatryan, Naira; Artornsombudh, Pichaporn; Pujari, Siddharth S; Foster, C Stephen; Jabs, Douglas A; Nussenblatt, Robert B; Rosenbaum, James T; Levy-Clarke, Grace A; Sen, H Nida; Suhler, Eric B; Thorne, Jennifer E; Bhatt, Nirali P; Kempen, John H.
Afiliação
  • Sobrin L; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. Electronic address: Lucia_Sobrin@meei.harvard.edu.
  • Pistilli M; Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania.
  • Dreger K; Department of Population, Family, and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Department of Ophthalmology, The Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Kothari S; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania; Department of Ophthalmology, Boston Children's Hospital, Boston, Massachusetts; Massachusetts Eye Rese
  • Khachatryan N; Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts.
  • Artornsombudh P; Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts; Department of Ophthalmology, Somdech Phra Pinkloa Hospital, Royal Thai Navy, Bangkok, Thailand; Depart
  • Pujari SS; Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts; Siddharth Netralaya, Belgaum, Karnataka, India.
  • Foster CS; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts.
  • Jabs DA; Departments of Ophthalmology and Medicine, The Icahn School of Medicine at Mount Sinai, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
  • Nussenblatt RB; Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
  • Rosenbaum JT; Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon; Department of Medicine, Oregon Health and Science University, Portland, Oregon; Legacy Devers Eye Institute, Portland, Oregon.
  • Levy-Clarke GA; Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland; The Tampa Bay Uveitis Center, St. Petersburg, Florida.
  • Sen HN; Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
  • Suhler EB; Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon; Department of Ophthalmology, Portland Veteran's Affairs Medical Center, Portland, Oregon.
  • Thorne JE; Department of Ophthalmology, The Johns Hopkins School of Medicine, Baltimore, Maryland; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
  • Bhatt NP; Department of Ophthalmology, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania.
  • Kempen JH; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; MCM Eye Unit, MyungSung Christian Medical Center and MyungSung Medical School, Addis Ababa, Ethiopia.
Ophthalmology ; 127(6): 826-834, 2020 06.
Article em En | MEDLINE | ID: mdl-31932091
ABSTRACT

PURPOSE:

To estimate the incidence of medication-free remission of chronic anterior uveitis and identify predictors thereof.

DESIGN:

Retrospective cohort study.

PARTICIPANTS:

Patients diagnosed with anterior uveitis of longer than 3 months' duration followed up at United States tertiary uveitis care facilities.

METHODS:

Estimation of remission incidence and identification of associated predictors used survival analysis. MAIN OUTCOME

MEASURES:

Incidence of medication-free remission. For the primary analysis, remission was defined as inactive uveitis while off treatment at all visits spanning an interval of at least 90 days or-for patients who did not return for follow-up after 90 days-remaining inactive without receiving suppressive medications at all of the last visits. Association of factors potentially predictive of medication-free remission was also studied.

RESULTS:

Two thousand seven hundred ninety-five eyes of 1634 patients with chronic anterior uveitis were followed up over 7936 eye-years (4676 person-years). The cumulative medication-free, person-year remission incidence within 5 years was 32.7% (95% confidence interval [CI], 30.4%-35.2%). Baseline clinical factors predictive of reduced remission incidence included longer duration of uveitis at presentation (for 2 to 5 years vs. less than 6 months adjusted hazard ratio [aHR], 0.61; 95% CI, 0.44-0.83), bilateral uveitis (aHR, 0.75; 95% CI, 0.59-0.96), prior cataract surgery (aHR, 0.70; 95% CI 0.56-0.88), and glaucoma surgery (aHR, 0.63; 95% CI, 0.45-0.90). Two time-updated characteristics were also predictive of reduced remission incidence keratic precipitates (aHR, 0.36; 95% CI, 0.21-0.60) and synechiae (aHR, 0.62; 95% CI, 0.41-0.93). Systemic diagnosis with juvenile idiopathic arthritis and spondyloarthropathy were also associated with reduced remission incidence. Older age at presentation was associated with higher incidence of remission (for age ≥40 years vs. <40 years aHR, 1.29; 95% CI, 1.02-1.63).

CONCLUSIONS:

Approximately one third of patients with chronic anterior uveitis remit within 5 years. Longer duration of uveitis, younger age, bilateral uveitis, prior cataract surgery, glaucoma surgery, presence of keratic precipitates and synechiae, and systemic diagnoses of juvenile idiopathic arthritis and spondyloarthropathy predict reduced remission incidence; patients with these factors should be managed taking into account the higher probability of a longer disease course.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Uveíte Anterior / Glucocorticoides / Imunossupressores Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Uveíte Anterior / Glucocorticoides / Imunossupressores Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Ano de publicação: 2020 Tipo de documento: Article